Your browser doesn't support javascript.
loading
Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments.
Garcia-Aymerich, Judith; Puhan, Milo A; Corriol-Rohou, Solange; de Jong, Corina; Demeyer, Heleen; Dobbels, Fabienne; Erzen, Damijan; Frei, Anja; Gimeno-Santos, Elena; Hopkinson, Nicholas S; Ivanoff, Nathalie; Karlsson, Niklas; Louvaris, Zafeiris; Polkey, Michael I; Rabinovich, Roberto A; Scuri, Mario; Tabberer, Maggie; Vogiatzis, Ioannis; Troosters, Thierry.
Afiliação
  • Garcia-Aymerich J; ISGlobal, Barcelona, Spain judith.garcia@isglobal.org.
  • Puhan MA; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Corriol-Rohou S; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • de Jong C; Epidemiology, Biostatistics & Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Demeyer H; AstraZeneca R&D, Paris, France.
  • Dobbels F; Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen,University Medical Center Groningen (UMCG), Groningen, The Netherlands.
  • Erzen D; Department of General Practice and Elderly Care, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
  • Frei A; Department of Respiratory Diseases, University Hospital Leuven, Leuven, Belgium.
  • Gimeno-Santos E; Department of Rehabilitation Sciences, KU Leuven -University of Leuven, Leuven, Belgium.
  • Hopkinson NS; Academic Centre for Nursing and Midwifery, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
  • Ivanoff N; Global Clinical Operations, Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach, Germany.
  • Karlsson N; Epidemiology, Biostatistics & Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Louvaris Z; Respiratory Clinic Institute, Hospital Clinic of Barcelona, Barcelona, Spain.
  • Polkey MI; Institut d'Investigacions Biomèdiques Agust Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Rabinovich RA; National Heart and Lung Institute, Imperial College London, London, UK.
  • Scuri M; Almirall S A, Barcelona, Spain.
  • Tabberer M; AstraZeneca, BioPharmaceuticals Medical, Gothenburg, Sweden.
  • Vogiatzis I; Department of Rehabilitation Sciences, KU Leuven -University of Leuven, Leuven, Belgium.
  • Troosters T; First Department of Respiratory Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Thorax ; 76(3): 228-238, 2021 03.
Article em En | MEDLINE | ID: mdl-33479044
ABSTRACT

BACKGROUND:

The Daily-PROactive and Clinical visit-PROactive Physical Activity (D-PPAC and C-PPAC) instruments in chronic obstructive pulmonary disease (COPD) combines questionnaire with activity monitor data to measure patients' experience of physical activity. Their amount, difficulty and total scores range from 0 (worst) to 100 (best) but require further psychometric evaluation.

OBJECTIVE:

To test reliability, validity and responsiveness, and to define minimal important difference (MID), of the D-PPAC and C-PPAC instruments, in a large population of patients with stable COPD from diverse severities, settings and countries.

METHODS:

We used data from seven randomised controlled trials to evaluate D-PPAC and C-PPAC internal consistency and construct validity by sex, age groups, COPD severity, country and language as well as responsiveness to interventions, ability to detect change and MID.

RESULTS:

We included 1324 patients (mean (SD) age 66 (8) years, forced expiratory volume in 1 s 55 (17)% predicted). Scores covered almost the full range from 0 to 100, showed strong internal consistency after stratification and correlated as a priori hypothesised with dyspnoea, health-related quality of life and exercise capacity. Difficulty scores improved after pharmacological treatment and pulmonary rehabilitation, while amount scores improved after behavioural physical activity interventions. All scores were responsive to changes in self-reported physical activity experience (both worsening and improvement) and to the occurrence of COPD exacerbations during follow-up. The MID was estimated to 6 for amount and difficulty scores and 4 for total score.

CONCLUSIONS:

The D-PPAC and C-PPAC instruments are reliable and valid across diverse COPD populations and responsive to pharmacological and non-pharmacological interventions and changes in clinically relevant variables.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psicometria / Qualidade de Vida / Exercício Físico / Tolerância ao Exercício / Doença Pulmonar Obstrutiva Crônica / Terapia por Exercício Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Thorax Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psicometria / Qualidade de Vida / Exercício Físico / Tolerância ao Exercício / Doença Pulmonar Obstrutiva Crônica / Terapia por Exercício Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Thorax Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha